Please login to the form below
FDA rejects Sarepta’s new Duchenne drug over safety fears
FDA gave no warnings of concerns, says chief exec
AZ claims first-in-class win for Farxiga in heart failure
AZ in pursuit of class leader Jardiance
UK no longer measles-free as vaccination rates fall dramatically
PM Boris Johnson calls for urgent action
Lilly’s Levi Garraway will replace Sandra Horning as Roche CMO
Garraway joins from Eli Lilly
Leaked no-deal Brexit document forecasts widespread shortages
Identifies risk of medicine shortages
AbbVie scores FDA approval for arthritis treatment upadacitinib
Could find it difficult to live up to Humira
Novo Nordisk shareholder revolt reaches Europe
Accused of lacking transparency over pricing pressures
BMS buoyed by FDA approval of Celgene’s myelofibrosis drug
Currently in the middle of merger
Sanofi patent case win holds off generic rivals for key cancer drug
Boosts hope of increasing future sales
Q&A: Jessica Pacey
PME interviews the founder and chief executive of newly launched health comms agency, 67health
-
Who's calling the shots in European healthcare?Patients versus Pharma: industry too powerful, and too cosy with EMA, says Yannis Natsis
-
Q&A with Tim CockroftPME interviews the founding director of akt health communications
-
Leo Pharma to market AstraZeneca’s brodalumab outside EuropeExtends reach of the drug
-
Regeneron scores positive data in phase 3 cholesterol trialTargets severe inherited disorder
-
Roche undercuts price of Bayer cancer drug after winning FDA approvalBoth drugs highly effective in small subset of patients
-
Government to set up ‘express freight service’ for medicinal products in event of no-deal Brexit Additional preparation to ensure continuity of supplies
-
US politicians round on generics firms for blocking drug pricing probeRenews focus on increases in generic drug prices
-
Potential cure for Ebola following trial successTwo treatments increased rates of survival
-
AZ, Merck’s Lynparza scores market-expanding clinical successPositive phase 3 findings in ovarian cancer
Latest appointments
-
Senior leadership moves announced at Publicis HealthNew roles will support European operations
-
Lucid Group announces new hires at its creative and digital agency Bluedog Follows group's success at Communiqué 2019
-
Recruiters PIR International appoint four new executivesWill fuel firm's international expansion
-
F-star hires ex-BMS immuno-oncology leader
New CMO to oversee development of lead candidate
-
Synergy Studio continues to growMohamed Alani joins team in Richmond
Featured jobs
- FREELANCE Account Director – Healthcare Advertising – London – 3...
-
Competitive Daily Rates
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
- Senior Account Executive – Account Manager – Healthcare Advertis...
-
£32000 - £43000 Bonus Benfits
- Account Director, Healthcare Communications
-
Salary TBC
-
Account Director – UK Office
-
Excellent salary and benefits
Subscribe to our email news alerts
- GSK hires Merck KGaA exec to lead US pharma business
- Novartis chooses internal replacement for US pharma president role
- Moving annual total (MAT)
- Roche undercuts price of Bayer cancer drug after winning FDA approval
- Novartis chooses internal replacement for US pharma president role
- Lilly psoriasis drug beats J&J's Tremfya in head-to-head trial
- A uniquely English genomic medicine service
- FDA rejects Sarepta’s new Duchenne drug over safety fears
- AZ claims first-in-class win for Farxiga in heart failure
- UK no longer measles-free as vaccination rates fall dramatically
- Lilly’s Levi Garraway will replace Sandra Horning as Roche CMO
- Blended Intelligence
PMHub
Wilmington Healthcare
A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...
Latest intelligence
- A uniquely English genomic medicine service
- The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
- Blended Intelligence
- Data is the most valued commodity of the modern world. For P&P it's all about the application....
- The relevance of patient perspectives to value
- Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
Quick links
Infographics
